Left Ventricular Assist System (LVAS)

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Advanced Refractory Left Ventricular Heart FailureCardiomyopathiesHeart Failure, CongestiveVentricular Dysfunction

Unknown Phase

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

CompletedNCT00121485

Abbott Medical DevicesCardiomyopathies, Heart Failure, Congestive, Ventricular Dysfunction

Start: 2005-02-28End: 2012-01-31Updated: 2022-06-27

HeartMate 3™ CE Mark Clinical Investigation Plan

CompletedNCT02170363

Abbott Medical DevicesAdvanced Refractory Left Ventricular Heart Failure

Start: 2014-06-30End: 2020-03-09Updated: 2022-06-27

Related Papers

Long-Term Evaluation of a Fully Magnetically Levitated Circulatory Support Device for Advanced Heart Failure—Two-Year Results from The Heartmate 3 CE Mark Study

European Journal of Heart Failure2018-07-2789 citations

Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.

2017-04-0470 citations

Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes

European Journal of Cardio-Thoracic Surgery2016-07-1946 citations

Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF

Journal of the American College of Cardiology2015-12-01229 citations

Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.

2012-01-26244 citations

Advanced heart failure treated with continuous-flow left ventricular assist device.

2009-11-172039 citations